Advanced search
Publication Cover
Journal of Chemotherapy Volume 35, 2023 - Issue 6
Submit an article Journal homepage
65
Views
0
CrossRef citations to date
0
Altmetric
Anticancer Original Research Papers

microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 2

Wenshan Chena Department of Anorectal, Xinchang Hospital Affiliated to Wenzhou Medical University, Zhejiang, China
,
Yun Chena Department of Anorectal, Xinchang Hospital Affiliated to Wenzhou Medical University, Zhejiang, China
&
Tong Huib Department of Anorectal, Shanxi Provincial People’s Hospital, Shanxi Province, ChinaCorrespondence[email protected]
Pages 539-549 | Received 17 Jun 2022, Accepted 08 Dec 2022, Published online: 22 Dec 2022

References

  • Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22–36.
  • Zhang N, Hu X, Du Y, et al. The role of miRNAs in colorectal cancer progression and chemoradiotherapy. Biomed Pharmacother. 2021;134:111099.
  • Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021;14(4):dmm047662.
  • Ali Syeda Z, Langden SSS, Munkhzul C, et al. Regulatory mechanism of MicroRNA expression in cancer. Int J Mol Sci. 2020;21(5):1723.
  • Hossian AKMN, Mackenzie GG, Mattheolabakis G. Combination of miR-143 and miR-506 reduces lung and pancreatic cancer cell growth through the downregulation of cyclin-dependent kinases. Oncol Rep. 2021;45(4):2.
  • Tang J, Pan H, Wang W, et al. MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer. Clin Transl Oncol. 2021;23(11):2323–2334.
  • Guo Y, Liang F, Zhao F, et al. Resibufogenin suppresses tumor growth and warburg effect through regulating miR-143-3p/HK2 axis in breast cancer. Mol Cell Biochem. 2020;466(1–2):103–115.
  • Dougherty U, Mustafi R, Zhu H, et al. Upregulation of polycistronic microRNA-143 and microRNA-145 in colonocytes suppresses colitis and inflammation-associated Colon cancer. Epigenetics. 2021;16(12):1317–1334.
  • Liu A, Liu L. Long non-coding RNA ZEB2-AS1 promotes proliferation and inhibits apoptosis of Colon cancer cells via miR-143/bcl-2 axis. Am J Transl Res. 2019;11(8):5240–5248.
  • He W, Zhang D, Li D, et al. Knockdown of long non-coding RNA LINC00200 inhibits gastric cancer progression by regulating miR-143-3p/SERPINE1 axis. Dig Dis Sci. 2021;66(10):3404–3414.
  • Huang F, Jiang J, Yao Y, et al. Circular RNA hsa_circRNA_101996 promotes the development of gastric cancer via upregulating matrix metalloproteinases-2/matrix metalloproteinases-9 through MicroRNA-143/ten-eleven translocation-2 pathway. J Cancer. 2021;12(22):6665–6675.
  • How CW, Teoh SL, Loh JS, et al. Emerging nanotheranostics for 5-fluorouracil in cancer therapy: a systematic review on efficacy, safety, and diagnostic capability. Front Pharmacol. 2022;13:882704.
  • Mahawongkajit P, Tomtitchong P. Expression of miRNA in 5-FU resistant esophageal cancer. Mol Clin Oncol. 2020;13(2):221–227.
  • Sethy C, Kundu CN. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair inhibition. Biomed Pharmacother. 2021;137:111285.
  • Santos EDS, Nogueira KAB, Fernandes LCC, et al. EGFR targeting for cancer therapy: pharmacology and immunoconjugates with drugs and nanoparticles. Int J Pharm. 2021;592:120082.
  • Gu XY, Jiang Y, Li MQ, et al. Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer. Aging (Albany NY). 2020;12(1):156–177.
  • Stine ZE, Schug ZT, Salvino JM, et al. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21(2):141–162.
  • Nava GM, Madrigal Perez LA. Metabolic profile of the warburg effect as a tool for molecular prognosis and diagnosis of cancer. Expert Rev Mol Diagn. 2022;22(4):439–447.
  • Gao SJ, Ren SN, Liu YT, et al. Targeting EGFR sensitizes 5-Fu-resistant Colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis. Mol Ther Oncolytics. 2021;23:14–25.
  • Avraham R, Sas-Chen A, Manor O, et al. EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors. Sci Signal. 2010;3(124):ra43.
  • Zhu H, Dougherty U, Robinson V, et al. EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine Colon cancer: role of G1 regulators. Mol Cancer Res. 2011;9(7):960–975.
  • Garcia SN, Guedes RC, Marques MM. Unlocking the potential of HK2 in cancer metabolism and therapeutics. Curr Med Chem. 2019;26(41):7285–7322.
  • Chen J, Yu Y, Li H, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer. 2019;18(1):33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.